glp-1 이란 당뇨·비만 잡고 간·뇌·심장 질환까지…식지않는 'GLP-1' 열풍 꿈의 비만 치료제 위고비 A

Semaglutide is well-tolerated, with minor side effects such as morning nausea and occasional vomiting [20]

Unlike some weight loss interventions that may lead to the loss of both fat and lean tissue, GLP-1-T appears to have a more targeted effect on reducing fat while maintaining lean body mass

faces higher GLP-1 drug prices due to market forces including research and development expenses, patent protections, demand outpacing supply and limited government regulation on drug pricing

Improved insulin response

Pathophysiology of obesity and HFpEF Patients with HFpEF exhibit an increase in overall cardiac volume, and this is more pronounced in obese individuals, manifesting as ventricular dilatation, ventricular wall thickening, and increases in the amount of epicardial adipose tissue (EAT) [24, 25]

Notch signalling: A simple pathway becomes complex